Attached files
| file | filename |
|---|---|
| 10-Q/A - FIRST CHINA PHARMACEUTICAL GROUP, INC. | v220432_10qa.htm |
| EX-31.2 - FIRST CHINA PHARMACEUTICAL GROUP, INC. | v220432_ex31-2.htm |
| EX-31.1 - FIRST CHINA PHARMACEUTICAL GROUP, INC. | v220432_ex31-1.htm |
| EX-32.1 - FIRST CHINA PHARMACEUTICAL GROUP, INC. | v220432_ex32-1.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of First China Pharmaceutical Group, Inc. (the “Company”) on Form 10-Q for the quarterly period ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yi Jia Li, Chief Financial Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
i.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
|
|
|
ii.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: April 29, 2011
|
/s/ Yi Jia Li
|
|
|
Name: Yi Jia Li
|
|
|
Title: Chief Financial Officer (Principal Financial Officer and
|
|
|
Principal Accounting Officer)
|